Group One Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Sell
219,700
-102,300
-32% -$14.3M 0.06% 331
2025
Q4
$39.5M Buy
322,000
+93,000
+41% +$11.3M 0.07% 269
2025
Q3
$25.4M Sell
229,000
-95,300
-29% -$10.8M 0.04% 401
2025
Q2
$36M Sell
324,300
-7,800
-2% -$830K 0.08% 232
2025
Q1
$37.2M Sell
332,100
-14,500
-4% -$1.5M 0.11% 147
2024
Q4
$32M Sell
346,600
-11,400
-3% -$1.03M 0.07% 232
2024
Q3
$30M Sell
358,000
-110,500
-24% -$8.43M 0.09% 179
2024
Q2
$32.1M Buy
468,500
+58,200
+14% +$3.88M 0.12% 119
2024
Q1
$30.1M Buy
410,300
+302,700
+281% +$23.3M 0.12% 119
2023
Q4
$8.72M Sell
107,600
-63,600
-37% -$4.95M 0.02% 771
2023
Q3
$12.8M Sell
171,200
-164,000
-49% -$12.6M 0.04% 388
2023
Q2
$25.8M Sell
335,200
-39,500
-11% -$3.15M 0.08% 170
2023
Q1
$31.1M Sell
374,700
-173,000
-32% -$14.3M 0.11% 126
2022
Q4
$47M Sell
547,700
-98,400
-15% -$7.79M 0.11% 157
2022
Q3
$39.9M Sell
646,100
-23,200
-3% -$1.46M 0.08% 170
2022
Q2
$41.4M Sell
669,300
-624,000
-48% -$38.6M 0.06% 231
2022
Q1
$76.9M Buy
1,293,300
+207,100
+19% +$13.2M 0.08% 159
2021
Q4
$78.9M Sell
1,086,200
-252,600
-19% -$17.4M 0.06% 203
2021
Q3
$93.5M Buy
1,338,800
+556,300
+71% +$39.1M 0.1% 131
2021
Q2
$53.9M Buy
782,500
+56,500
+8% +$3.77M 0.07% 236
2021
Q1
$46.9M Sell
726,000
-169,700
-19% -$10.9M 0.07% 236
2020
Q4
$52.2M Sell
895,700
-261,800
-23% -$15.8M 0.09% 178
2020
Q3
$73.1M Sell
1,157,500
-2,259,100
-66% -$157M 0.23% 59
2020
Q2
$263M Buy
3,416,600
+1,561,100
+84% +$120M 1.21% 4
2020
Q1
$139M Buy
1,855,500
+1,712,400
+1,197% +$118M 1.12% 5
2019
Q4
$9.3M Sell
143,100
-9,500
-6% -$619K 0.06% 380
2019
Q3
$9.67M Buy
152,600
+16,500
+12% +$1.08M 0.08% 285
2019
Q2
$9.2M Sell
136,100
-168,300
-55% -$11.1M 0.08% 255
2019
Q1
$19.8M Sell
304,400
-920,000
-75% -$61.1M 0.22% 67
2018
Q4
$76.6M Buy
1,224,400
+866,100
+242% +$60.5M 0.66% 13
2018
Q3
$27.7M Buy
358,300
+202,300
+130% +$15.3M 0.22% 73
2018
Q2
$11.1M Sell
156,000
-55,500
-26% -$3.92M 0.09% 225
2018
Q1
$15.9M Sell
211,500
-27,700
-12% -$2.2M 0.16% 114
2017
Q4
$17.1M Sell
239,200
-38,400
-14% -$2.92M 0.12% 175
2017
Q3
$22.5M Buy
277,600
+238,800
+615% +$18.3M 0.2% 92
2017
Q2
$2.75M Sell
38,800
-131,700
-77% -$8.76M 0.03% 772
2017
Q1
$11.6M Buy
170,500
+56,300
+49% +$3.96M 0.13% 163
2016
Q4
$8.18M Buy
114,200
+18,100
+19% +$1.35M 0.08% 282
2016
Q3
$7.6M Sell
96,100
-101,900
-51% -$8.28M 0.08% 265
2016
Q2
$16.5M Buy
198,000
+20,200
+11% +$1.79M 0.2% 85
2016
Q1
$16.3M Sell
177,800
-55,700
-24% -$5.02M 0.23% 69
2015
Q4
$23.6M Buy
233,500
+96,500
+70% +$10M 0.28% 49
2015
Q3
$13.5M Sell
137,000
-14,600
-10% -$1.62M 0.19% 95
2015
Q2
$17.7M Sell
151,600
-2,800
-2% -$306K 0.25% 64
2015
Q1
$15.2M Buy
154,400
+5,300
+4% +$538K 0.24% 59
2014
Q4
$14.1M Buy
+149,100
New +$15.4M 0.21% 78
2014
Q2
Sell
-500
Closed -$35K 5272
2014
Q1
$35K Sell
500
-12,300
-96% -$965K ﹤0.01% 3894
2013
Q4
$962K Sell
12,800
-1,200
-9% -$83.6K 0.01% 1122
2013
Q3
$880K Sell
14,000
-8,000
-36% -$478K 0.02% 1112
2013
Q2
$1.13M Buy
+22,000
New +$1.15M 0.03% 737

Other funds holding GILD

Group One Trading's GILD Position: Q1 2026 in Review

Group One Trading opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,959 shares worth $970K. The stake represents ﹤0.01% of the portfolio and ranks #2755 among its holdings. This is a return to the name: Group One Trading previously reported a position in GILD as recently as Q2 2025.

Group One Trading first reported a position in GILD in Q1 2014 and has held it in 34 quarters since. The position peaked at $62.9M in Q2 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Group One Trading held 6,959 shares of Gilead Sciences worth $970K as of Q1 2026.
  • Gilead Sciences was a new Group One Trading position in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2755 holding.
  • Group One Trading first reported a position in Gilead Sciences in Q1 2014 and has held it in 34 quarters since.
  • Group One Trading's Gilead Sciences position peaked at $62.9M in Q2 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.